Table 4.
Condition | Techniques | Overall (n=154) | Indonesia (n=16) | Korea (n=47) | Malaysia (n=15) | Mongolia (n=24) | Myanmar (n=7) | Thailand (n=40) | Vietnam (n=5) |
---|---|---|---|---|---|---|---|---|---|
Pedunculated polyps with head size <20 mm and stalk width <10 mm | CSP | 11 (7.1) | 1 (6.3) | 0 | 1 (6.7) | 7 (29.2) | 0 | 2 (5.0) | 0 |
HSP | 100 (64.9)* | 13 (81.3)* | 15 (31.9) | 13 (86.7)* | 13 (54.2)* | 6 (85.7)* | 35 (87.5)* | 5 (100)* | |
EMR | 40 (26.0) | 2 (12.5) | 32 (68.1)* | 1 (6.7) | 2 (8.3) | 1 (14.3) | 2 (5.0) | 0 | |
ESD | 3 (1.9) | 0 | 0 | 0 | 2 (8.3) | 0 | 1 (2.5) | 0 | |
Prophylactic hemostasis | Clipping | 91 (59.1)* | 12 (75.0)* | 15 (31.9) | 5 (33.3) | 21 (87.5)* | 5 (71.4)* | 30 (75.0)* | 3 (60.0)* |
Detachable snare | 10 (6.5) | 1 (6.3) | 2 (4.3) | 1 (6.7) | 3 (12.5) | 1 (14.3) | 1 (2.5) | 1 (20.0) | |
None | 53 (34.4) | 3 (18.8) | 30 (63.8)* | 9 (60.0)* | 0 | 1 (14.3) | 9 (22.5) | 1 (20.0) | |
Pedunculated polyps with head size ≥20 mm or stalk width ≥10 mm | CSP | 1 (0.6) | 0 | 0 | 0 | 0 | 1 (14.3) | 0 | 0 |
HSP | 90 (58.4)* | 12 (75.0)* | 12 (25.5) | 13 (86.7)* | 11 (45.8)* | 6 (85.7)* | 32 (80.0)* | 4 (80.0)* | |
EMR | 58 (37.7) | 4 (25.0) | 34 (72.3)* | 2 (13.3) | 11 (45.8)* | 0 | 6 (15.0) | 1 (20.0) | |
ESD | 3 (1.9) | 0 | 1 (2.1) | 0 | 2 (8.3) | 0 | 0 | 0 | |
Others† | 2 (1.3) | 0 | 0 | 0 | 0 | 0 | 2 (5.0) | 0 | |
Prophylactic hemostasis | Clipping | 87 (56.5)* | 7 (43.8)* | 20 (42.6)* | 7 (46.7)* | 20 (83.3)* | 4 (57.1)* | 28 (70.0)* | 1 (20.0) |
Detachable snare | 51 (33.1) | 7 (43.8)* | 19 (40.4) | 4 (26.7) | 4 (16.7) | 3 (42.9) | 11 (27.5) | 3 (60.0)* | |
None | 16 (10.4) | 2 (12.5) | 8 (17.0) | 4 (26.7) | 0 | 0 | 1 (2.5) | 1 (20.0) |
Values are presented as number (%).
CSP, cold snare polypectomy; HSP, hot snare polypectomy; EMR, endoscopic mucosal resection; ESD, endoscopic submucosal dissection.
*The most preferred method for each condition; †Others indicates referring the case to specialist endoscopists.